Q32 Bio Inc.
DE ˙ DB
10,47 € ↓ -0,52 (-4,73%)
2026-06-03
DEL PRIS
SecurityDE:DB0 / Q32 Bio Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership9,560 shares
Latest Disclosed Value $ 61,375
Morgan Stanley reports 74.52% increase in ownership of DB0 / Q32 Bio Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 9,560 shares of Q32 Bio Inc. (DE:DB0) valued at $51,146 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 5,478 shares of Q32 Bio Inc.. This represents a change in shares of 74.52% during the quarter. The current value of the position is $100,093 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Q32 BIO COM 746964105 9,560 4,082 74.52 61 238.89 0.0000
2026-05-27 2025-12-31 13F/A-1 Q32 BIO COM 746964105 5,478 -5,865 -51.71 18 -18.18 0.0000
2026-02-13 2025-12-31 13F Q32 BIO COM 746964105 5,478 -5,865 18 0.0000
2026-05-27 2025-09-30 13F/A-1 Q32 BIO COM 746964105 11,343 -7,305 -39.17 22 -18.52 0.0000
2025-11-14 2025-09-30 13F Q32 BIO COM 746964105 11,343 -7,305 22 0.0000
2025-08-15 2025-06-30 13F Q32 BIO COM 746964105 18,648 3,991 27.23 28 12.50 0.0000
2025-05-15 2025-03-31 13F Q32 BIO COM 746964105 14,657 -58,205 -79.88 24 -90.40 0.0000
2025-05-15 2024-12-31 13F/A-1 Q32 BIO COM 746964105 72,862 56,346 341.16 251 -66.03 0.0000
2025-02-14 2024-12-31 13F Q32 BIO COM 746964105 72,862 56,346 251 0.0000
2025-05-14 2024-09-30 13F/A-2 Q32 BIO COM 746964105 16,516 9,758 144.39 737 508.26 0.0001
2025-02-14 2024-09-30 13F/A-1 Q32 BIO COM 746964105 16,516 9,758 737 0.0001
2024-11-14 2024-09-30 13F Q32 BIO COM 746964105 16,516 9,758 737 0.0001
2025-05-14 2024-06-30 13F/A-2 Q32 BIO COM 746964105 6,758 6,035 834.72 121 908.33 0.0000
2024-10-17 2024-06-30 13F/A-1 Q32 BIO COM 746964105 6,758 6,035 121 0.0000
2024-08-14 2024-06-30 13F Q32 BIO COM 746964105 6,758 6,035 121 0.0000
2024-10-17 2024-03-31 13F/A-2 Q32 BIO COM 746964105 723 723 12 0.0000
2024-08-16 2024-03-31 13F/A-1 Q32 BIO COM 746964105 723 723 12 0.0000
2024-05-15 2024-03-31 13F Q32 BIO COM 746964105 723 723 12 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.